FindTrial
Sign In

Granulocyte Colony-Stimulating Factor (G-CSF) and Interleukin-8 (IL-8) for early diagnosis of sepsis in neonates and critically ill children: safety and cost effectiveness of a new laboratory prediction model

Not provided at time of registration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN91123847
Enrollment
Unknown
Registered
2003-10-28
Start date
2003-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis in neonates and critically ill children Infections and Infestations Sepsis in children

Interventions

New laboratory markers for infection given to physicians in charge of the patients in order to improve diagnostic work-up.

Sponsors

Chance for the Critically Ill Child Foundation (Stiftung Chance fuer das kritisch kranke Kind) (Switzerland)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Newborns and critically ill paediatric patients of a tertiary University Children's Hospital

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

Switzerland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026